Sun Pharmaceutical Industries stock ended 2.15 per cent higher on Friday after zooming by almost 5 per cent in the morning ...

Incyte Corp. closed 32.26% below its 52-week high of $83.95, which the company achieved on November 8th.

The US Court of Appeals for the Federal Circuit vacated a preliminary injunction on Leqselvi’s launch, lifting restrictions ...

Emkay Global Financial is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 2400 in its ...

Emkay Global Financial Services, in a client note, described the development as “materially positive,” as it removes a key ...

Emkay Global maintains a 'Buy' rating on Sun Pharma after the US Court of Appeals vacates the injunction against Leqselvi's ...

Sun Pharma shares gained after a U.S. court lifted an injunction, clearing the way for the launch of LEQSELVI, its drug for ...

Incyte Corp. closed 34.28% below its 52-week high of $83.95, which the company achieved on November 8th.

Sun Pharmaceutical Industries on Thursday said that it has received a major relief from a US court, which allowed it to ...

Even inadvertent participation by a law clerk on a matter involving their future employer may call into question the court’s ...

After a legal decision delayed its entry last fall, Sun Pharma has received the all-clear to tap into the U.S. | After Sun ...

On April 9, 2025, the US Court of Appeals for the Federal Circuit held an oral argument on the company's appeal of the US ...